Revealing Edible Bird Nest as Novel Functional Foods in Combating Metabolic Syndrome: Comprehensive In Silico, In Vitro, and In Vivo Studies
Nutrients · 2023
DOI: 10.3390/nu15183886 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2023. Verfasst von Happy Kurnia Permatasari und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biomolecular, Faculty of Medicine, University of Brawijaya, Malang 65145, Indonesia. Hauptthemen laut MEDLINE: Functional Food, Metabolic Syndrome. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate School Innovation office, Kyung Hee University, a grant from Kyung Hee University in 2023, Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT).
Abstract (Originalsprache)
Metabolic dysfunction, which includes intra-abdominal adiposity, glucose intolerance, insulin resistance, dyslipidemia, and hypertension, manifests into metabolic syndrome and related diseases. Therefore, the discovery of new therapies in the fight against metabolic syndrome is very challenging. This study aims to reveal the existence of an edible bird nest (EBN) as a functional food candidate that may be a new alternative in fighting metabolic syndrome. The study included three approaches: in silico molecular docking simulation, in vitro, and in vivo in rats fed on cholesterol- and fat-enriched diets. Four terpenoids of Bakuchiol, Curculigosaponin A, Dehydrolindestrenolide, and 1-methyl-3-(1-methyl-ethyl)-benzene in EBN have been identified through LCMS/MS-QTOF. In molecular docking simulations, Bakuchiol and Dehydrolindestrenolide are considered very potent because they have higher inhibitory power on the four receptors (iNOS, ROS1 kinase, FTO, and lipase) than standard drugs. In vitro tests also provide insight into the antioxidant, antidiabetic, and antiobesity activities of EBN, which is quite feasible due to the smaller EC50 value of EBN compared to standard drugs. Interestingly, in vivo studies also showed significant improvements (p < 0.05) in the lipid profile, blood glucose, enzymatic levels, and inflammatory biomarkers in rats given high-dose dietary supplementation of EBN. More interestingly, high-dose dietary supplementation of EBN upregulates PGC-1α and downregulates HMG-CoA reductase. Comprehensively, it has been revealed that EBN can be novel functional foods for combating metabolic syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biomolecular, Faculty of Medicine, University of Brawijaya, Malang 65145, Indonesia.
- Department of Pharmacy, Faculty of Medicine, University of Brawijaya, Malang 65145, Indonesia.
- Division of Clinical Nutrition, Department of Nutrition, Faculty of Medicine, Hasanuddin University, Makassar 90245, Indonesia.
- Department of Biotechnology, Faculty of Biotechnology, Atma Jaya Catholic University of Indonesia, Jakarta 12930, Indonesia.
- Diabetes Connection Care, Eka Hospital Bumi Serpong Damai, Tangerang 15321, Indonesia.
- Department of Food Technology, Faculty of Engineering, Bina Nusantara University, Jakarta 11480, Indonesia.
ORCID-Profile: Happy Kurnia Permatasari, Nurpudji Astuti Taslim, Rudy Kurniawan, Reggie Surya, Faqrizal Ria Qhabibi, Nelly Mayulu, Netty Salindeho, Moon Nyeo Park, Juan Alessandro Jeremis Maruli Nura Lele, Raymond R Tjandrawinata, Bonglee Kim, Fahrul Nurkolis
Förderung
- Graduate School Innovation office, Kyung Hee University, a grant from Kyung Hee University in 2023
- Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education
- the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
- the innovation network support Program through the INNOPOLIS funded by Ministry of Science and ICT
- Graduate School Innovation office, Kyung Hee University
- Ministry of Science and ICT
Zitieren
APA
Permatasari, H. K., Permatasari, Q. I., Taslim, N. A., Subali, D., Kurniawan, R., Surya, R., Qhabibi, F. R., Tanner, M. J., Batubara, S. C., Mayulu, N., Gunawan, W. B., Syauki, A. Y., Salindeho, N., Park, M. N., Lele, J. A. J. M. N., Tjandrawinata, R. R., Kim, B., & Nurkolis, F. (2023). Revealing Edible Bird Nest as Novel Functional Foods in Combating Metabolic Syndrome: Comprehensive In Silico, In Vitro, and In Vivo Studies. Nutrients. https://doi.org/10.3390/nu15183886
Vancouver
Permatasari HK, Permatasari QI, Taslim NA, Subali D, Kurniawan R, Surya R, et al. Revealing Edible Bird Nest as Novel Functional Foods in Combating Metabolic Syndrome: Comprehensive In Silico, In Vitro, and In Vivo Studies. Nutrients. 2023. doi:10.3390/nu15183886
BibTeX
@article{Permatasari2023,
author = {Permatasari, Happy Kurnia and Permatasari, Queen Intan and Taslim, Nurpudji Astuti and Subali, Dionysius and Kurniawan, Rudy and Surya, Reggie and Qhabibi, Faqrizal Ria and Tanner, Melvin Junior and Batubara, Siti Chairiyah and Mayulu, Nelly and Gunawan, William Ben and Syauki, Andi Yasmin and Salindeho, Netty and Park, Moon Nyeo and Lele, Juan Alessandro Jeremis Maruli Nura and Tjandrawinata, Raymond R and Kim, Bonglee and Nurkolis, Fahrul},
title = {Revealing Edible Bird Nest as Novel Functional Foods in Combating Metabolic Syndrome: Comprehensive In Silico, In Vitro, and In Vivo Studies},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15183886}
}
EUVIMED